Intravitreal bevacizumab for vitreous haemorrhage

Acta Ophthalmol. 2008 Aug;86(5):585-6. doi: 10.1111/j.1600-0420.2007.01107.x. Epub 2007 Dec 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Humans
  • Injections
  • Middle Aged
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity
  • Vitreous Body
  • Vitreous Hemorrhage / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab